Latanoprost and Ear disorder - a phase IV clinical study of FDA data

Summary:

Ear disorder is reported as a side effect among people who take Latanoprost (latanoprost), especially for people who are female, 60+ old, also take Omacor, and have Pain.

The phase IV clinical study analyzes which people have Ear disorder when taking Latanoprost. It is created by eHealthMe based on reports of 32,842 people who have side effects when taking Latanoprost from the FDA, and is updated regularly.

What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 33,250 Latanoprost users. Check the latest studies of Latanoprost.

What is Ear disorder?

Ear disorder is found to be associated with 592 drugs and 1,110 conditions by eHealthMe. Check the latest studies of Ear disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

32,842 people reported to have side effects when taking Latanoprost.
Among them, 24 people (0.07%) have Ear disorder.

Among these 24 people:

What is the gender of people who have Ear disorder when taking Latanoprost? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Ear disorder when taking Latanoprost? *

What are other drugs people take besides Latanoprost? *

What are other side effects people have besides Ear disorder? *

Malaise (a feeling of general discomfort or uneasiness): 13 people, 54.17%
Weakness: 13 people, 54.17%
Fatigue (feeling of tiredness): 12 people, 50.00%
Weight Decreased: 12 people, 50.00%
Peripheral Swelling: 10 people, 41.67%
Depression: 9 people, 37.50%
Vision Blurred: 9 people, 37.50%
Muscle Spasms (muscle contraction): 8 people, 33.33%
Skin Depigmentation (lightening of the skin): 8 people, 33.33%
Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 8 people, 33.33%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 33.33%
Constipation: 8 people, 33.33%
Depression: 8 people, 33.33%
High Blood Cholesterol: 8 people, 33.33%
Pain: 8 people, 33.33%
Indigestion: 4 people, 16.67%
Eye Disorder: 4 people, 16.67%
Nervousness: 4 people, 16.67%
Urinary Tract Disorder: 3 people, 12.50%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Latanoprost and have Ear disorder?

- Check whether Ear disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latanoprost:

Latanoprost (33,250 reports)

Ear disorder treatments and more:

Ear disorder (6,288 reports)

Browse all side effects of Latanoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear disorder:

Ear disorder (592 drugs)

Browse all the conditions that are associated with Ear disorder:

Ear disorder (1,110 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Latanoprost) and Latanoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.